The increased risk associated with insulin therapy has also been demonstrated in a study by Cariou et al., who showed that in patients with type 2 diabetes who were hospitalized with a SARS-CoV-2 infection, insulin therapy was related to an increased mortality rate [18]. This evidence concerns the gene INS and type 2 diabetes mellitus.